SKYA vs MCK vs BDX Stock Comparison

SkyAI, Mckesson and Becton Dickinson Prices as of Oct 26, 2026 Peers: Industry group
SKYA SkyAI, Inc.
$2.89 +53.7% 1M -42.8% 1Y
Market cap
$210.15M
P/E
–
Revenue (TTM)
$194.22K
Div. yield
–
Medical Supplies Healthcare
2 wins
MCK Mckesson Corp
$992.64 +14.5% 1M +23.8% 1Y
Market cap
$114.87B
P/E
25.0x
Revenue (TTM)
$410.98B
Div. yield
0.00%
Drug Distribution Healthcare
7 wins
BDX Becton Dickinson & Co
$196.39 +6.8% 1M +5.7% 1Y
Market cap
$53.61B
P/E
57.0x
Revenue (TTM)
$23.25B
Div. yield
–
Medical Supplies Healthcare
2 wins

Head to Head

11 decided of 12

Mckesson leads on 7 of the 12 questions below (Mckesson 7, SkyAI 2, Becton Dickinson 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionSKYAMCKBDXLeader
Larger companyMarket capitalisation $210.15M $114.87B $53.61B MCK
Cheaper on earningsLower P/E, profitable companies only -0.7x 25.0x 57.0x MCK
Cheaper on forward earningsLower price / next fiscal year consensus EPS 0.0x 21.1x 15.1x SKYA
Faster revenue growthRevenue growth, trailing twelve months +108.9% +8.8% +17.4% SKYA
More profitableNet margin, trailing twelve months -158,431.4% 1.1% 4.0% BDX
Better return on capitalReturn on invested capital — 107.9% 5.3% MCK
Less leveragedLower net debt / EBITDA — 0.6x 3.2x MCK
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -42.8% +23.8% +5.7% MCK
Better 5-year returnAnnualised price return, 5 years — +37.4%/yr -4.3%/yr MCK
Less volatileAnnualised volatility, 1 year 106.2% 30.7% 31.9% MCK
Higher overall scoreMean of the five percentile scores vs peers 26/100 58/100 67/100 BDX

Percentile Scorecard

SKYAMCKBDX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisSKYAMCKBDX
Valuation 2 #223 of 228 50 #13 of 25 90 #24 of 228
Growth 6 #207 of 221 65 #9 of 24 47 #117 of 221
Profitability 1 #206 of 208 65 #9 of 24 78 #46 of 208
Financial Health 94 #16 of 239 48 #14 of 26 27 #176 of 239
Shareholder Returns – 60 #7 of 16 95 #8 of 137
Overall 26 58 67
  • SKYA ranked among 248 companies in Medical Devices and Diagnostics
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • BDX ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodSKYAMCKBDXSPY
1 month +53.7%+14.5%+6.8% -0.8%
3 months +118.9%+16.7%+23.6% +3.5%
6 months +61.5%+19.8%+30.7% +7.0%
Year to date +42.4%+21.0%+1.2% +12.2%
1 year -42.8%+23.8%+5.7% +13.0%
3 years -99.9%+121.6%-21.9% +86.3%
3 years, per year -90.1%+30.4%-7.9% +23.1%
5 years —+388.9%-19.8% +68.6%
5 years, per year —+37.4%-4.3% +11.0%
10 years —+526.0%+17.2% +258.0%
10 years, per year —+20.1%+1.6% +13.6%

Risk

MeasureSKYAMCKBDXSPY
Volatility, 1Y 106.2%30.7%31.9% 12.7%
Downside volatility, 1Y 104.5%27.3%33.1% 12.7%
Beta vs S&P 500, 1Y 2.59-0.260.34 1.00
Return / volatility, 1Y -0.400.780.18 1.02
Max drawdown, 5Y -100.0%-27.2%-50.4% -25.4%
From 52-week high -46.6%-3.6%-6.5% -1.8%
52-week high $5.41$1,030.18$210.02 $779.14
52-week low $0.95$725.17$140.71 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleSKYAMCKBDX
P/E now vs peer median -0.7xmedian 30.6x 25.7xmedian 24.3x 57.3xmedian 30.6x
P/S now vs peer median 1,073xmedian 3.0x 0.3xmedian 0.3x 2.3xmedian 3.0x
EV/EBITDA now vs peer median —median 17.5x 16.6xmedian 13.5x 14.0xmedian 17.5x
P/FCF now vs peer median —median 23.3x 18.0xmedian 15.6x 16.7xmedian 23.3x
P/B now vs peer median 1.3xmedian 2.4x -27.3xmedian 2.5x 2.2xmedian 2.4x
PEG now vs peer median 0.01median 0.87 2.15median 1.33 -3.93median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsSKYAMCKBDX
Revenue $194.22K $410.98B $23.25B
Gross profit $321.93K $14.96B $10.91B
Operating income -$289.52M $6.50B $2.48B
Net income -$307.71M $5.30B $941.00M
Free cash flow – $6.42B $3.20B
R&D $399.91K – $1.37B
EPS (diluted) $-4.27 $38.52 $3.42
Cash & equivalents $12.07M $5.16B $708.00M
Total debt – $9.73B $72.81B
Shares (diluted) 72.09M 119.20M 275.16M
Enterprise value $168.85M $98.77B $50.76B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricSKYAMCKBDX
P/E -0.7x 25.7x 57.3x
P/FCF – 18.0x 16.7x
P/Operating cash flow – 16.9x 13.5x
P/S 1,073x 0.3x 2.3x
P/B 1.3x -27.3x 2.2x
P/Tangible book 16.0x -14.0x 2.2x
EV/EBITDA – 16.6x 14.0x
EV/EBIT -0.7x 18.5x 28.0x
EV/Revenue 1,011x 0.3x 3.0x
EV/FCF – 18.8x 21.7x
EV/Operating cash flow – 17.6x 17.6x
PEG (3Y EPS CAGR) 0.01 2.15 -3.93

Growth

14 metrics
MetricSKYAMCKBDX
Revenue growth (1Y) 108.9% 8.8% 17.4%
Revenue CAGR (3Y) 23.8% 13.1% 6.9%
Gross profit growth (1Y) – 11.2% 23.7%
Gross profit CAGR (3Y) – 6.6% 8.5%
Operating income growth (1Y) -5,525% 46.6% 13.0%
Operating income CAGR (3Y) -212.8% 13.5% 3.3%
Net income growth (1Y) -42,440% 58.1% -40.6%
Net income CAGR (3Y) -238.0% 10.7% -17.3%
EPS growth (1Y) -487.2% 52.8% -38.0%
EPS CAGR (3Y) -84.2% 12.0% -14.6%
Operating cash flow growth (1Y) – 4.7% 43.5%
Operating cash flow CAGR (3Y) – 10.7% 14.5%
Free cash flow growth (1Y) – 6.8% 54.2%
Free cash flow CAGR (3Y) – 11.3% 22.5%

Profitability

14 metrics
MetricSKYAMCKBDX
Gross margin 165.8% 3.6% 46.9%
EBITDA margin – 1.8% 21.4%
Operating margin -149,065% 1.6% 10.7%
Pretax margin -151,352% 1.6% 8.4%
Net margin -158,431% 1.1% 4.0%
FCF margin – 1.6% 13.8%
Operating cash flow margin – 1.7% 17.0%
Return on equity -140.2% – 3.9%
Return on assets -137.6% 6.2% 1.9%
Return on invested capital – 107.9% 5.3%
Return on capital employed -136.7% 43.4% 6.0%
Asset turnover 0.0x 4.8x 0.5x
Cash conversion (OCF / net income) – 1.3x 4.2x
Stock comp / revenue 48,037% – 1.2%

Financial Health

11 metrics
MetricSKYAMCKBDX
Debt / assets – 11.0% 33.1%
Debt / equity – -2.3x 0.7x
Net debt / EBITDA – 0.6x 3.2x
Debt / FCF – 1.5x 5.2x
Liabilities / assets 1.9% 104.8% 51.9%
Equity / assets 98.1% -4.8% 48.1%
Interest coverage – 23.6x 4.2x
Current ratio 5.3x 0.9x 0.9x
Quick ratio 4.4x 0.5x 0.3x
Cash ratio 4.2x 0.1x 0.1x
Altman Z-score 31.13 5.90 2.29

Shareholder Returns

7 metrics
MetricSKYAMCKBDX
Dividend yield – 0.3% 2.1%
Net buyback yield – 5.7% 4.7%
Shareholder yield – 6.1% 6.8%
Payout ratio (earnings) – 7.4% –
Payout ratio (FCF) – 6.1% –
Dividend growth (1Y) – 11.3% –
Dividend CAGR (3Y) – 10.0% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusSKYAMCKBDX
Forward P/E 0.0xFY2026 21.1xFY2026 15.1xFY2026
EPS, next fiscal year $2,362.06FY2026 $47.15FY2026 $12.99FY2026
EPS growth, next FY – +20.6%FY2026 +14.8%FY2026
EPS growth, the year after – +11.0% -2.9%
Revenue, next fiscal year $70.01MFY2026 $444.47BFY2026 $18.11BFY2026
Revenue growth, next FY +34,200.1%FY2026 +10.2%FY2026 -17.1%FY2026
Revenue growth, the year after +17.5% +1.5% +11.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersSKYAMCKBDX
Held by institutions – 89.1% 96.1%
Institutions holding – 2,007 1,442
Change in shares held, QoQ – -0.7% +0.6%
Institutions buying – 879 688
Institutions selling – 791 543
Buyers to sellers – 1.11 1.27

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

SKYAMCKBDX
SKYA 1.00 -0.11 0.11
MCK -0.11 1.00 0.24
BDX 0.11 0.24 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, SKYA, MCK and BDX?

Mckesson (MCK) is the largest by market capitalisation: SkyAI (SKYA) $210.15M, Mckesson (MCK) $114.87B, Becton Dickinson (BDX) $53.61B.

Which stock is cheaper, SKYA, MCK and BDX?

Mckesson (MCK) trades on the lowest price-to-earnings ratio (SkyAI (SKYA) -0.7x, Mckesson (MCK) 25.0x, Becton Dickinson (BDX) 57.0x). On next year's consensus earnings, SkyAI (SKYA) is cheapest (SkyAI (SKYA) 0.0x, Mckesson (MCK) 21.1x, Becton Dickinson (BDX) 15.1x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: SkyAI (SKYA) +108.9%, Mckesson (MCK) +8.8%, Becton Dickinson (BDX) +17.4%.

Which company is more profitable?

Becton Dickinson (BDX) has the highest net margin (SkyAI (SKYA) -158,431.4%, Mckesson (MCK) 1.1%, Becton Dickinson (BDX) 4.0%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 107.9%, Becton Dickinson (BDX) 5.3%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: SkyAI (SKYA) -42.8%, Mckesson (MCK) +23.8%, Becton Dickinson (BDX) +5.7%. Over five years, Mckesson (MCK) compounded fastest (Mckesson (MCK) +37.4%/yr, Becton Dickinson (BDX) -4.3%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: SkyAI (SKYA) 0.00%, Mckesson (MCK) 0.00%, Becton Dickinson (BDX) 0.00%. SkyAI (SKYA) and Becton Dickinson (BDX) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (SkyAI (SKYA) 106.2%, Mckesson (MCK) 30.7%, Becton Dickinson (BDX) 31.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, SKYA, MCK and BDX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.